EcoDrugPlus

Catechol-O-Methyltransferase

Ensembl ID : ENSCAFG00020007849
Gene Symbol: COMT
3 Cross references
277 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSCAFG00020016953
Gene Symbol: CTSC
2 Cross references
229 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSCAFG00020019521
Gene Symbol: CTSK
3 Cross references
246 Possible Orthologues:

Cathepsin S

Ensembl ID : ENSCAFG00020019528
Gene Symbol: CTSS
3 Cross references
270 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSCAFG00020013566
Gene Symbol: CDC7
3 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSCAFG00020010694
Gene Symbol: CHEK1
3 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSCAFG00020022441
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSCAFG00020027326
Gene Symbol: CCKAR
3 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSCAFG00020009516
Gene Symbol: CCKBR
3 Cross references
270 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSCAFG00020013229
Gene Symbol: CHRM1
3 Cross references
104 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSCAFG00020026786
Gene Symbol: CHRM2
3 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSCAFG00020025250
Gene Symbol: CHRM3
3 Cross references
257 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).